Enovis director granted 9,346 common shares

Kelly Liam reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kelly Liam reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Liam Kelly received a grant of 9,346 shares of common stock. The award was reported at a price of $0.00 per share, indicating it was a compensation-related grant rather than an open-market purchase. Following this grant, Kelly directly holds a total of 28,950 Enovis common shares.

Insider Trade Summary

Grant/Award: 9,346 shares

Grant/Award 1 txn

Insider Kelly Liam

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.001	9,346	$0.00	$0.00

Holdings After Transaction: Common stock, par value $0.001 — 28,950 shares (Direct)

Key Figures

Shares granted: 9,346 shares Grant price per share: $0.00 per share Shares owned after grant: 28,950 shares

3 metrics

Shares granted 9,346 shares Common stock grant reported on May 19, 2026

Grant price per share $0.00 per share Reported for the 9,346-share award

Shares owned after grant 28,950 shares Total direct holdings following the reported transaction

Key Terms

Common stock, par value $0.001, Grant, award, or other acquisition, transaction code "A"

3 terms

Common stock, par value $0.001 financial

"security_title: "Common stock, par value $0.001""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

transaction code "A" regulatory

"transaction_code: "A" for the reported stock grant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Enovis (ENOV) director Liam Kelly report in this Form 4?

Liam Kelly reported receiving a grant of 9,346 Enovis common shares. The shares were awarded at $0.00 per share as compensation, increasing his direct holdings to 28,950 shares of Enovis CORP common stock after the transaction.

Was Liam Kelly’s Enovis (ENOV) Form 4 transaction a market purchase or sale?

The Form 4 shows a grant, not a market trade. Kelly received 9,346 Enovis common shares as a stock award at $0.00 per share, so there was no open-market buying or selling involved in this specific transaction.

How many Enovis (ENOV) shares does Liam Kelly own after this Form 4 grant?

After receiving the 9,346-share grant, Liam Kelly directly owns 28,950 Enovis common shares. This total reflects his position reported immediately following the compensation-related award disclosed in the Form 4 filing.

What is the transaction code used in Liam Kelly’s Enovis (ENOV) Form 4?

The transaction uses code "A," which indicates a grant, award, or other acquisition. In this case, Liam Kelly received 9,346 Enovis common shares as a stock award, rather than purchasing them in the open market.

Does the Enovis (ENOV) Form 4 for Liam Kelly indicate any share disposals?

No, the Form 4 only reports an acquisition. It shows a single "A" coded transaction for a grant of 9,346 shares, raising Liam Kelly’s direct ownership to 28,950 shares, with no disposals or sales reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 08:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelly Liam

(Last) (First) (Middle)

2711 CENTERVILLE ROAD

SUITE 400

(Street)

WILMINGTON DELAWARE 19808

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	05/19/2026		A		9,346	A	$0.00	28,950	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian P. Hanigan, attorney-in-fact	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)